SEELY LYNN sold 9.1% of their position (7.46K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $174.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2026ACC: 0001327111-26-000002
-7.46K
Net shares
Net seller
$174.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.46K
Price / share
$23.39
Trade value
$174.37K
% of position
9.1%
2/11/2026
81.72K→74.27K
Total
Net shares
−7.46K
Net value
-$174.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | S · Sale | −7.46K | $23.39 | $174.37K | 9.1% | 81.72K | 74.27K |
| Total | −7.46K | -$174.37K | ||||||
Derivative Transactions0
No derivative transactions reported